⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL468412 | 1.00 | — | — | |
| SCHEMBL18266153 | 0.78 | — | — | |
| SCHEMBL21078966 | 0.76 | LMNA (0.33) | — | |
| SCHEMBL20053118 | 0.75 | — | — | |
| SCHEMBL10686269 | 0.75 | — | — | |
| SCHEMBL10686260 | 0.75 | — | — | |
| SCHEMBL4544101 | 0.75 | — | — | |
| SCHEMBL4544097 | 0.75 | — | — | |
| SCHEMBL8068005 | 0.75 | — | — | |
| SCHEMBL4438376 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7659215-B2 | Method of depositing nanolaminate film for non-volatile floating gate memory devices by atomic layer deposition | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2010-02-09 | — | — | US | claimed |
| WO-2009018368-A1 | COMBINATION TREATMENT OF NMDA (N-METHYL-D-ASPARTATE)-ENHANCER, GLYCINE TRANSPORTER INHIBITOR, D-AMINO ACID OXIDASE INHIBITOR (DAAOI) FOR NEUROPSYCHIATRIC DISORDERS | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) | 2009-02-05 | — | — | WO | claimed |
| US-20080054332-A1 | METHOD OF DEPOSITING NANOLAMINATE FILM FOR NON-VOLATILE FLOATING GATE MEMORY DEVICES BY ATOMIC LAYER DEPOSITION | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2008-03-06 | — | — | US | claimed |
| US-20230197509-A1 | WET FUNCTIONALIZATION OF DIELECTRIC SURFACES | LAM RESEARCH CORPORATION | 2023-06-22 | — | — | US | disclosed |
| US-11529342-B2 | Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical | LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER (US) | 2022-12-20 | — | — | US | disclosed |
| US-11522133-B2 | Correlated electron device formed via conversion of conductive substrate to a correlated electron region | CERFE LABS, INC. (US) | 2022-12-06 | — | — | US | disclosed |
| US-11258010-B2 | Formation of a correlated electron material (CEM) | CERFE LABS, INC. (US) | 2022-02-22 | — | — | US | disclosed |
| WO-2021236886-A1 | WET FUNCTIONALIZATION OF DIELECTRIC SURFACES | LAM RESEARCH CORPORATION (US) | 2021-11-25 | — | — | WO | disclosed |
| US-11075339-B2 | Correlated electron material (CEM) devices with contact region sidewall insulation | CERFE LABS, INC. (US) | 2021-07-27 | — | — | US | disclosed |
| US-20210226124-A1 | ELECTRODE FOR CORRELATED ELECTRON DEVICE | CERFE LABS, INC. | 2021-07-22 | — | — | US | disclosed |
| US-11011701-B2 | Switching device formed from correlated electron material | CERFE LABS, INC. (US) | 2021-05-18 | — | — | US | disclosed |
| EP-1896451-A2 | BICYCLIC DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH | Pfizer Products Incorporated (US) | 2008-03-12 | — | — | EP | disclosed |
| US-20080054332-A1 | METHOD OF DEPOSITING NANOLAMINATE FILM FOR NON-VOLATILE FLOATING GATE MEMORY DEVICES BY ATOMIC LAYER DEPOSITION | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2008-03-06 | — | — | US | disclosed |
| US-20070072885-A1 | BICYCLIC DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH | PFIZER INC | 2007-03-29 | — | — | US | disclosed |
| WO-2006129168-A2 | BICYCLIC DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH | PFIZER PRODUCTS INC. (US) | 2006-12-07 | — | — | WO | disclosed |
| EP-1412515-A2 | TREATMENT OF CNS DISORDERS USING D-AMINO ACID OXIDASE AND D-ASPARTATE OXIDASE ANTAGONISTS | Genset (FR) | 2004-04-28 | — | — | EP | disclosed |
| US-20030185754-A1 | Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists | GENSET, S.A. (FR) | 2003-10-02 | — | — | US | disclosed |
| US-20030166554-A1 | Treatment of CNS disorders using D-amino acid oxidase and D-aspartate oxidase antagonists | GENSET, S.A. (FR) | 2003-09-04 | — | — | US | disclosed |
| WO-2003047558-A2 | TREATMENT OF CNS DISORDERS USING D-AMINO ACID OXIDASE AND D-ASPARTATE OXIDASE INHIBITORS | GENSET S.A. (FR) | 2003-06-12 | — | — | WO | disclosed |
| WO-2002066672-A2 | TREATMENT OF CNS DISORDERS USING D-AMINO ACID OXIDASE AND D-ASPARTATE OXIDASE ANTAGONISTS | GENSET S.A. (FR) | 2002-08-29 | — | — | WO | disclosed |